BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25620088)

  • 1. Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nishio M; Takase N; Utsunomiya S; Akiyama H; Kakeji Y; Komori T; Koma Y; Yokozaki H
    Cancer Med; 2015 Mar; 4(3):437-46. PubMed ID: 25620088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nakamura T; Nishio M; Watajima T; Kuroda D; Komori T; Kakeji Y; Semba S; Yokozaki H
    Cancer Sci; 2013 Aug; 104(8):1112-9. PubMed ID: 23648122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.
    Kodama T; Koma YI; Arai N; Kido A; Urakawa N; Nishio M; Shigeoka M; Yokozaki H
    Lab Invest; 2020 Sep; 100(9):1140-1157. PubMed ID: 32457351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Software-assisted morphometric and phenotype analyses of human peripheral blood monocyte-derived macrophages induced by a microenvironment model of human esophageal squamous cell carcinoma.
    Nishio M; Urakawa N; Shigeoka M; Takase N; Ichihara Y; Arai N; Koma Y; Yokozaki H
    Pathol Int; 2016 Feb; 66(2):83-93. PubMed ID: 26778807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways.
    Urakawa N; Utsunomiya S; Nishio M; Shigeoka M; Takase N; Arai N; Kakeji Y; Koma Y; Yokozaki H
    Lab Invest; 2015 May; 95(5):491-503. PubMed ID: 25730371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.
    Takase N; Koma Y; Urakawa N; Nishio M; Arai N; Akiyama H; Shigeoka M; Kakeji Y; Yokozaki H
    Cancer Lett; 2016 Sep; 380(1):47-58. PubMed ID: 27317650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive correlation of cysteine-rich 61 and target genes of Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
    Wang P; Li L; Li T
    J Cancer Res Ther; 2016 Oct; 12(Supplement):19-22. PubMed ID: 27721245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.
    Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A
    J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANXA10 induction by interaction with tumor-associated macrophages promotes the growth of esophageal squamous cell carcinoma.
    Kodaira H; Koma YI; Hosono M; Higashino N; Suemune K; Nishio M; Shigeoka M; Yokozaki H
    Pathol Int; 2019 Mar; 69(3):135-147. PubMed ID: 30758105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma.
    Zhou ZQ; Cao WH; Xie JJ; Lin J; Shen ZY; Zhang QY; Shen JH; Xu LY; Li EM
    BMC Cancer; 2009 Aug; 9():291. PubMed ID: 19698122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD163
    Kubota K; Moriyama M; Furukawa S; Rafiul HASM; Maruse Y; Jinno T; Tanaka A; Ohta M; Ishiguro N; Yamauchi M; Sakamoto M; Maehara T; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
    Sci Rep; 2017 May; 7(1):1755. PubMed ID: 28496107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Cyr61 in the growth, invasiveness and adhesion of esophageal squamous cell carcinoma cells.
    Xie JJ; Xu LY; Xie YM; Du ZP; Feng CH; Dong H; Li EM
    Int J Mol Med; 2011 Mar; 27(3):429-34. PubMed ID: 21249313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells.
    Xie JJ; Xu LY; Wu JY; Shen ZY; Zhao Q; Du ZP; Lv Z; Gu W; Pan F; Xu XE; Xie D; Li EM
    Am J Pathol; 2010 Feb; 176(2):939-51. PubMed ID: 20056838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway.
    Fujikawa M; Koma YI; Hosono M; Urakawa N; Tanigawa K; Shimizu M; Kodama T; Sakamoto H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Am J Pathol; 2021 Apr; 191(4):686-703. PubMed ID: 33460563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
    Yu X; Huang M; Yang G
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.
    Nakajima S; Mimura K; Saito K; Thar Min AK; Endo E; Yamada L; Kase K; Yamauchi N; Matsumoto T; Nakano H; Kanke Y; Okayama H; Saito M; Neupane P; Saze Z; Watanabe Y; Hanayama H; Hayase S; Kaneta A; Momma T; Ohki S; Ohira H; Kono K
    Mol Cancer Res; 2021 Jun; 19(6):1085-1095. PubMed ID: 33674443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.
    Yang H; Zhang Q; Xu M; Wang L; Chen X; Feng Y; Li Y; Zhang X; Cui W; Jia X
    Mol Cancer; 2020 Feb; 19(1):41. PubMed ID: 32103760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERK expression and its correlation with STAT1 in esophageal squamous cell carcinoma.
    Wang H; Zhang Y; Yun H; Chen S; Chen Y; Liu Z
    Oncotarget; 2017 Jul; 8(28):45249-45258. PubMed ID: 28431406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.